HTML

It’s not the evidence, it’s the way you use it: is clinical practice being tyrannised by evidence?
Kathy Stiller — Aust Health Rev 2008; 32 (2): 204-207.

HTML

Towards a socio-political understanding of the pharmaceutical sector
Hans Lofgren — Aust Health Rev 2004; 28 (2): 147-149.

HTML

Pharmaceuticals, the state and the global harmonisation process
John Abraham — Aust Health Rev 2004; 28 (2): 150-160.

HTML

Catching up in pharmaceuticals: government policies and the rise of genomics
Mats Benner — Aust Health Rev 2004; 28 (2): 161-170.

HTML

Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency
Peter Davis — Aust Health Rev 2004; 28 (2): 171-181.

HTML

India’s pharmaceutical industry: hype or high tech take-off?
Prabodh Malhotra and Hans Lofgren — Aust Health Rev 2004; 28 (2): 182-193.

HTML

The subsidy of pharmaceuticals in Australia: processes and challenges
Lloyd Sansom — Aust Health Rev 2004; 28 (2): 194-205.

HTML

Some drugs more equal than others: pseudo-generics and commercial practice
Andrew J Probyn — Aust Health Rev 2004; 28 (2): 207-217.

HTML

Patents, pills and politics: the Australia–United States Free Trade Agreement and the Pharmaceutical Benefits Scheme
Ken Harvey — Aust Health Rev 2004; 28 (2): 218-226.

HTML

Pharmaceuticals and the consumer movement: the ambivalences of ‘patient power’
Hans Lofgren — Aust Health Rev 2004; 28 (2): 228-237.

HTML

Community pharmacy in Australia
Shalom I Benrimoj and Michael S Frommer — Aust Health Rev 2004; 28 (2): 238-246.